PENTASA 2g extended release pellets medication leaflet

A07EC02 mesalazine • Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents

Mesalazine is a medication used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It is effective for both inducing remission and maintaining it, helping to reduce inflammation in the intestinal lining.

Mesalazine works locally in the intestine by inhibiting the production of inflammatory substances, such as prostaglandins and leukotrienes. It is available in the form of tablets, suppositories, or enemas, depending on the location of the inflammation in the digestive tract.

Side effects are usually mild and may include nausea, abdominal pain, diarrhea, headache, or skin rashes. In rare cases, more serious reactions can occur, such as kidney or liver dysfunction or severe allergic reactions. It is important to take mesalazine as prescribed by a doctor, with regular blood and urine tests to monitor for potential complications.

General data about PENTASA 2g

Substance: mesalazine

Date of last drug list: 01-06-2025

Commercial code: W61355001

Concentration: 2g

Pharmaceutical form: extended release pellets

Quantity: 60

Product type: original

Price: 383.77 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: FERRING GMBH - GERMANIA

Holder: FERRING GMBH - GERMANIA

Number: 12514/2019/01

Shelf life: 2 years

Concentrations available for mesalazine

1000mg, 1200mg, 1g, 1g/dose, 250mg, 2g, 400mg, 4g/60ml, 500mg, 800mg

Other substances similar to mesalazine

Compensation lists for PENTASA 2g FERRING

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

383.77 RON

224.66 RON

159.11 RON